Interstitial Lung Disease PBMC

Interstitial lung disease PBMC

PBMC samples from donors diagnosed with Interstitial lung disease are collected and processed under rigorous standards. These samples support research into alveolar damage and fibrotic remodeling, offering insights into disease mechanisms, biomarker discovery, and therapeutic development.

Product Features

  • PBMC isolated from clinically confirmed Interstitial lung disease donors
  • Rigorous donor screening and sample quality checks
  • Suitable for downstream applications such as flow cytometry, RNA-seq, ELISA, and qPCR

De-identified Donor Data

  • Age, sex, race, medication, diagnosis method, disease severity/stage
  • Optional: comorbidities, lab values, and clinical history

Applications

  • Immunophenotyping
  • Transcriptomics & proteomics
  • Biomarker validation
  • Therapeutic development and screening

Quality and Compliance

  • IRB-approved protocols
  • Informed donor consent
  • Standardized collection and processing SOPs

Ordering & Shipping

Samples are available in both standard and custom volumes to meet your research needs.

International Orders: For international shipments or country-specific documentation requirements, please contact us at learnmore@sanguinebio.com to ensure compliance with your local regulations.

Protocols & Documentation

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Frequently Asked Questions

Showing 13–24 of 30 results

Do samples come with donor screening reports?

1 Answer

All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/

YES – Certificate of analysis is available upon request.

Lead times vary from ready to ship inventory to prospective studies.

International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.

We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/

You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/

NO – no minimum order requirements.

For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com

YES – Fresh leukopaks can be delivered same day in select locations. Often, leukopaks are shipped same day as collection, thus arriving next day.

Contact learnmore@sanguinebio.com for current inventory. The website states “over 150 verified-conditions from ready-to-ship to prospective collections.” View our ready to ship products: https://sanguinebio.com/products/?pro_inventory=inventory

YES – Matched samples across multiple matrices are available, including synovial fluid are available.

1 2 3
×

Ask a Question

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information